Skye Bioscience, Inc.SKYENASDAQ
Loading
Interest Expense Over TimeContracting
Percentile Rank31
3Y CAGR-87.0%
5Y CAGR-71.0%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
-87.0%/yr
vs +62.7%/yr prior
5Y CAGR
-71.0%/yr
Recent deceleration
Acceleration
-149.7pp
Decelerating
Percentile
P31
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $1452.00 | -99.8% |
| 2024 | $967602.00 | +6.8% |
| 2023 | $906270.00 | +36.5% |
| 2022 | $663774.00 | -13.5% |
| 2021 | $767511.00 | +8.7% |
| 2020 | $706385.00 | -29.4% |
| 2019 | $1.00M | +956.0% |
| 2018 | $94763.00 | +14107.3% |
| 2017 | $667.00 | - |
| 2016 | $0.00 | - |